AU5572500A - Vegf receptor antagonists - Google Patents

Vegf receptor antagonists

Info

Publication number
AU5572500A
AU5572500A AU55725/00A AU5572500A AU5572500A AU 5572500 A AU5572500 A AU 5572500A AU 55725/00 A AU55725/00 A AU 55725/00A AU 5572500 A AU5572500 A AU 5572500A AU 5572500 A AU5572500 A AU 5572500A
Authority
AU
Australia
Prior art keywords
receptor antagonists
vegf receptor
vegf
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55725/00A
Inventor
Hajime Asanuma
Masakazu Sato
Masabumi Shibuya
Tetsuo Takayama
Hisaya Wada
Takehiro Yamagishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of AU5572500A publication Critical patent/AU5572500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU55725/00A 1999-07-01 2000-07-03 Vegf receptor antagonists Abandoned AU5572500A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP11/188270 1999-07-01
JP18826999 1999-07-01
JP18827099 1999-07-01
JP11/188269 1999-07-01
PCT/JP2000/004405 WO2001001981A1 (en) 1999-07-01 2000-07-03 Vegf receptor antagonists

Publications (1)

Publication Number Publication Date
AU5572500A true AU5572500A (en) 2001-01-22

Family

ID=26504824

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55725/00A Abandoned AU5572500A (en) 1999-07-01 2000-07-03 Vegf receptor antagonists

Country Status (2)

Country Link
AU (1) AU5572500A (en)
WO (1) WO2001001981A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005014077B4 (en) 2005-03-23 2012-05-24 Forschungszentrum Jülich GmbH Interconnector for high-temperature fuel cells and method for its production and method for operating a fuel cell
JP2010526038A (en) * 2007-05-03 2010-07-29 ノイロサーチ アクティーゼルスカブ Β-keto-amide derivatives useful as ion channel modulators
CA2723233C (en) 2008-05-08 2017-06-13 Nova Southeastern University Specific inhibitors for vascular endothelial growth factor receptors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH628161A5 (en) * 1976-12-24 1982-02-15 Ciba Geigy Ag COLOR PHOTOGRAPHIC MATERIAL.
GB9424232D0 (en) * 1994-11-30 1995-01-18 Univ Birmingham Growth factor expression
US6022307A (en) * 1998-07-14 2000-02-08 American Cyanamid Company Substituted dibenzothiophenes having antiangiogenic activity

Also Published As

Publication number Publication date
WO2001001981A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
AU5274499A (en) Therapeutic chemokine receptor antagonists
AU2002367424A1 (en) Androgen receptor antagonists
AU4797400A (en) Metabotropic glutamate receptor antagonists
AUPR833401A0 (en) G protein-coupled receptor antagonists
AU4698299A (en) 5-HT7 receptor antagonists
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
AU5095000A (en) Receptor interacting protein rip3
AU2001264657A1 (en) Crf receptor antagonists
HUP0201524A3 (en) Bradykinin receptor antagonists
IL144875A0 (en) Receptor assay
AU2441801A (en) Urotensin-ii receptor antagonists
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU2001286409A1 (en) N-methyl-d-aspartate receptor antagonists
IL146151A0 (en) Human-g-protein receptor
AU6990000A (en) Novel integrin receptor antagonists
AU2001240021A1 (en) Diazafluorenone il-8 receptor antagonists
AU1073501A (en) Histamine receptor
AU2002226048A1 (en) Urotensin-ii receptor antagonists
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
AU2002216079A1 (en) Bombesin receptor antagonists
AU2002239506A1 (en) Urotensin-ii receptor antagonists
AU5786300A (en) Muscarinic antagonists
AU2001249573A1 (en) Chemokine receptor antagonists
AU5861900A (en) Receptor agonists and antagonists
AU2002359524A1 (en) P2x7 receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase